These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17721804)

  • 1. A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
    Jiang BH; Maruyama J; Yokochi A; Mitani Y; Maruyama K
    Lung; 2007; 185(5):303-308. PubMed ID: 17721804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystamine Treatment Fails to Prevent the Development of Pulmonary Hypertension in Chronic Hypoxic Rats.
    Markvardsen LK; Sønderskov LD; Wandall-Frostholm C; Pinilla E; Prat-Duran J; Aalling M; Mogensen S; Andersen CU; Simonsen U
    J Vasc Res; 2021; 58(4):237-251. PubMed ID: 33910208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats.
    Zhang E; Maruyama J; Yokochi A; Mitani Y; Sawada H; Nishikawa M; Ma N; Maruyama K
    J Anesth; 2015 Oct; 29(5):715-23. PubMed ID: 25931318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
    Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
    J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged nitric oxide inhalation fails to regress hypoxic vascular remodeling in rat lung.
    Jiang BH; Maruyama J; Yokochi A; Iwasaki M; Amano H; Mitani Y; Maruyama K
    Chest; 2004 Jun; 125(6):2247-52. PubMed ID: 15189948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular iNOS induction participates in the onset of chronic hypoxic pulmonary hypertension.
    Hampl V; Bíbová J; Banasová A; Uhlík J; Miková D; Hnilicková O; Lachmanová V; Herget J
    Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L11-20. PubMed ID: 16113050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
    Tan JX; Huang XL; Wang B; Fang X; Huang DN
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of panax notoginseng saponins injection on the p38MAPK pathway in lung tissue in a rat model of hypoxic pulmonary hypertension.
    Zhao S; Zheng MX; Chen HE; Wu CY; Wang WT
    Chin J Integr Med; 2015 Feb; 21(2):147-51. PubMed ID: 25523598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of all-trans-retinoic acid on the development of chronic hypoxia-induced pulmonary hypertension.
    Zhang E; Jiang B; Yokochi A; Maruyama J; Mitani Y; Ma N; Maruyama K
    Circ J; 2010 Aug; 74(8):1696-703. PubMed ID: 20606328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes.
    Jiang BH; Maruyama J; Yokochi A; Amano H; Mitani Y; Maruyama K
    Eur Respir J; 2002 Jul; 20(1):52-8. PubMed ID: 12166581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension.
    Fagan KA; Morrissey B; Fouty BW; Sato K; Harral JW; Morris KG; Hoedt-Miller M; Vidmar S; McMurtry IF; Rodman DM
    Respir Res; 2001; 2(5):306-13. PubMed ID: 11686901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.
    Wu Q; Wang HY; Li J; Zhou P; Wang QL; Zhao L; Fan R; Wang YM; Xu XZ; Yi DH; Yu SQ; Pei JM
    PLoS One; 2013; 8(5):e60850. PubMed ID: 23667430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
    Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
    Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.
    Liu B; Wang XQ; Yu L; Zhou TF; Wang XM; Liu HM
    Exp Lung Res; 2009 Jun; 35(5):411-26. PubMed ID: 19842842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercapnia attenuates hypoxic pulmonary hypertension by inhibiting lung radical injury.
    Chovanec M; Novotná J; Wilhelm J; Hampl V; Vízek M; Herget J
    Physiol Res; 2009; 58 Suppl 2():S79-S86. PubMed ID: 20131939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
    Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
    Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial dysfunction in insulin resistant obese Zucker rats.
    Moral-Sanz J; Menendez C; Moreno L; Moreno E; Cogolludo A; Perez-Vizcaino F
    Respir Res; 2011 Apr; 12(1):51. PubMed ID: 21513515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.